Skip to main content

Table 3 Pathways significantly enriched in hypermethylated DMCs in the LGA group according to WikiPathways [36]

From: Methylation analysis by targeted bisulfite sequencing in large for gestational age (LGA) newborns: the LARGAN cohort

Term

Overlap

P value

Adjusted P value

Odds ratio

Combined score

Genes

Heart Development WP1591

8/44

5.15E-05

0.015

7.071

69.826

TBX1;FOXC1;SHH;BMP2;HAND2;FOXH1;TBX5;TBX2

Development of ureteric collection system WP5053

8/47

8.42E-05

0.015

6.526

61.233

FOXC1;SHH;WT1;SIX2;LHX1;GATA3;FAT4;HOXD11

LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258

11/94

1.47E-04

0.018

4.228

37.300

APC2;TFAP2A;WNT10A;WNT2B;MYC;FZD7;TCF7;DVL1;FZD10;NOTUM;NKD1

Breast cancer pathway WP4262

14/154

3.00E-04

0.022

3.196

25.934

APC2;WNT10A;CDKN1A;WNT2B;NOTCH4;FZD7;TCF7;FZD10;FGF17;DLL4;MYC;DVL1;ERBB2;PGR

ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336

10/86

3.08E-04

0.022

4.192

33.893

WNT10A;WNT2B;MYC;FZD7;TCF7;DVL1;FZD10;NOTUM;KLF4;NKD1

Somatic sex determination WP4814

4/14

6.97E-04

0.043

12.662

92.038

NR5A1;WT1;AMH;PTGDS

Melatonin metabolism and effects WP3298

6/37

8.58E-04

0.045

6.140

43.356

ACHE;MTNR1A;AANAT;CYP1B1;APOE;FOXO1

  1. Only pathways with corrected p < 0.05 are shown